262 related articles for article (PubMed ID: 36516754)
1. Recruited monocytes/macrophages drive pulmonary neutrophilic inflammation and irreversible lung tissue remodeling in cystic fibrosis.
Öz HH; Cheng EC; Di Pietro C; Tebaldi T; Biancon G; Zeiss C; Zhang PX; Huang PH; Esquibies SS; Britto CJ; Schupp JC; Murray TS; Halene S; Krause DS; Egan ME; Bruscia EM
Cell Rep; 2022 Dec; 41(11):111797. PubMed ID: 36516754
[TBL] [Abstract][Full Text] [Related]
2. Myeloid CFTR loss-of-function causes persistent neutrophilic inflammation in cystic fibrosis.
Ng HP; Jennings S; Wellems D; Sun F; Xu J; Nauseef WM; Wang G
J Leukoc Biol; 2020 Dec; 108(6):1777-1785. PubMed ID: 32531843
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory Activity of Epithelial Stem Cell Variants from Cystic Fibrosis Lungs Is Not Resolved by CFTR Modulators.
Wang S; Niroula S; Hoffman A; Khorrami M; Khorrami M; Yuan F; Gasser GN; Choi S; Liu B; Li J; Metersky ML; Vincent M; Crum CP; Boucher RC; Karmouty-Quintana H; Huang HJ; Sheshadri A; Dickey BF; Parekh KR; Engelhardt JF; McKeon FD; Xian W
Am J Respir Crit Care Med; 2023 Nov; 208(9):930-943. PubMed ID: 37695863
[No Abstract] [Full Text] [Related]
4. Increased susceptibility of Cftr-/- mice to LPS-induced lung remodeling.
Bruscia EM; Zhang PX; Barone C; Scholte BJ; Homer R; Krause DS; Egan ME
Am J Physiol Lung Cell Mol Physiol; 2016 Apr; 310(8):L711-9. PubMed ID: 26851259
[TBL] [Abstract][Full Text] [Related]
5. Harnessing Neutrophil Survival Mechanisms during Chronic Infection by
Marteyn BS; Burgel PR; Meijer L; Witko-Sarsat V
Front Cell Infect Microbiol; 2017; 7():243. PubMed ID: 28713772
[TBL] [Abstract][Full Text] [Related]
6. Emerging Concepts in Defective Macrophage Phagocytosis in Cystic Fibrosis.
Jaganathan D; Bruscia EM; Kopp BT
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887098
[TBL] [Abstract][Full Text] [Related]
7. Loss of CFTR function in macrophages alters the cell transcriptional program and delays lung resolution of inflammation.
Wellems D; Hu Y; Jennings S; Wang G
Front Immunol; 2023; 14():1242381. PubMed ID: 38035088
[TBL] [Abstract][Full Text] [Related]
8. Anti-Inflammatory Influences of Cystic Fibrosis Transmembrane Conductance Regulator Drugs on Lung Inflammation in Cystic Fibrosis.
Harwood KH; McQuade RM; Jarnicki A; Schneider-Futschik EK
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299226
[TBL] [Abstract][Full Text] [Related]
9. Optimal complement-mediated phagocytosis of Pseudomonas aeruginosa by monocytes is cystic fibrosis transmembrane conductance regulator-dependent.
Van de Weert-van Leeuwen PB; Van Meegen MA; Speirs JJ; Pals DJ; Rooijakkers SH; Van der Ent CK; Terheggen-Lagro SW; Arets HG; Beekman JM
Am J Respir Cell Mol Biol; 2013 Sep; 49(3):463-70. PubMed ID: 23617438
[TBL] [Abstract][Full Text] [Related]
10. Expression of S100A8 correlates with inflammatory lung disease in congenic mice deficient of the cystic fibrosis transmembrane conductance regulator.
Tirkos S; Newbigging S; Nguyen V; Keet M; Ackerley C; Kent G; Rozmahel RF
Respir Res; 2006 Mar; 7(1):51. PubMed ID: 16571124
[TBL] [Abstract][Full Text] [Related]
11. Mutations of Cystic Fibrosis Transmembrane Conductance Regulator Gene Cause a Monocyte-Selective Adhesion Deficiency.
Sorio C; Montresor A; Bolomini-Vittori M; Caldrer S; Rossi B; Dusi S; Angiari S; Johansson JE; Vezzalini M; Leal T; Calcaterra E; Assael BM; Melotti P; Laudanna C
Am J Respir Crit Care Med; 2016 May; 193(10):1123-33. PubMed ID: 26694899
[TBL] [Abstract][Full Text] [Related]
12. Cystic fibrosis transmembrane conductance regulator dysfunction in platelets drives lung hyperinflammation.
Ortiz-Muñoz G; Yu MA; Lefrançais E; Mallavia B; Valet C; Tian JJ; Ranucci S; Wang KM; Liu Z; Kwaan N; Dawson D; Kleinhenz ME; Khasawneh FT; Haggie PM; Verkman AS; Looney MR
J Clin Invest; 2020 Apr; 130(4):2041-2053. PubMed ID: 31961827
[TBL] [Abstract][Full Text] [Related]
13. Subacute TGFβ expression drives inflammation, goblet cell hyperplasia, and pulmonary function abnormalities in mice with effects dependent on CFTR function.
Kramer EL; Hardie WD; Madala SK; Davidson C; Clancy JP
Am J Physiol Lung Cell Mol Physiol; 2018 Sep; 315(3):L456-L465. PubMed ID: 29877096
[TBL] [Abstract][Full Text] [Related]
14. Monocyte chemoattractant chemokines in cystic fibrosis.
Rao S; Wright AK; Montiero W; Ziegler-Heitbrock L; Grigg J
J Cyst Fibros; 2009 Mar; 8(2):97-103. PubMed ID: 19000946
[TBL] [Abstract][Full Text] [Related]
15. Recruitment of monocytes primed to express heme oxygenase-1 ameliorates pathological lung inflammation in cystic fibrosis.
Di Pietro C; Öz HH; Zhang PX; Cheng EC; Martis V; Bonfield TL; Kelley TJ; Jubin R; Abuchowski A; Krause DS; Egan ME; Murray TS; Bruscia EM
Exp Mol Med; 2022 May; 54(5):639-652. PubMed ID: 35581352
[TBL] [Abstract][Full Text] [Related]
16. Elevated Mirc1/Mir17-92 cluster expression negatively regulates autophagy and CFTR (cystic fibrosis transmembrane conductance regulator) function in CF macrophages.
Tazi MF; Dakhlallah DA; Caution K; Gerber MM; Chang SW; Khalil H; Kopp BT; Ahmed AE; Krause K; Davis I; Marsh C; Lovett-Racke AE; Schlesinger LS; Cormet-Boyaka E; Amer AO
Autophagy; 2016 Nov; 12(11):2026-2037. PubMed ID: 27541364
[TBL] [Abstract][Full Text] [Related]
17. Vardenafil reduces macrophage pro-inflammatory overresponses in cystic fibrosis through PDE5- and CFTR-dependent mechanisms.
Noel S; Panin N; Beka M; Dhooghe B; Huaux F; Leal T
Clin Sci (Lond); 2017 Jun; 131(11):1107-1121. PubMed ID: 28196856
[TBL] [Abstract][Full Text] [Related]
18. Myofibroblast differentiation and enhanced TGF-B signaling in cystic fibrosis lung disease.
Harris WT; Kelly DR; Zhou Y; Wang D; MacEwen M; Hagood JS; Clancy JP; Ambalavanan N; Sorscher EJ
PLoS One; 2013; 8(8):e70196. PubMed ID: 23950911
[TBL] [Abstract][Full Text] [Related]
19. Invariant natural killer T (iNKT) cells prevent autoimmunity, but induce pulmonary inflammation in cystic fibrosis.
Siegmann N; Worbs D; Effinger F; Bormann T; Gebhardt M; Ulrich M; Wermeling F; Müller-Hermelink E; Biedermann T; Tighe M; Edwards MJ; Caldwell C; Leadbetter E; Karlsson MC; Becker KA; Gulbins E; Döring G
Cell Physiol Biochem; 2014; 34(1):56-70. PubMed ID: 24977481
[TBL] [Abstract][Full Text] [Related]
20. Cystic fibrosis transmembrane regulator correction attenuates heart failure-induced lung inflammation.
Uhl FE; Vanherle L; Meissner A
Front Immunol; 2022; 13():928300. PubMed ID: 35967318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
